Putting the award page together from the records…
Putting the award page together from the records…
STUDY TO EVALUATE THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES HANNON ACT COMMITTEE
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
5 actions since 2023-04-13. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-11-25 | P00005 | Supplemental agreement (work within scope) | -$557 | STUDY TO EVALUATE THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES HANNON ACT COMMITTEE |
| 2024-07-16 | P00004 | Supplemental agreement (work within scope) | $0 | STUDY TO EVALUATE THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES HANNON ACT COMMITTEE |
| 2024-04-23 | P00003 | Supplemental agreement (work within scope) | -$48.1K | STUDY TO EVALUATE THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES HANNON ACT COMMITTEE |
| 2023-07-19 | P00002 | Option exercised | $1.86M | STUDY TO EVALUATE THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES HANNON ACT COMMITTEE |
| 2023-04-13 | P00001 | Supplemental agreement (work within scope) | -$112.2K | STUDY TO EVALUATE THE EFFECTS OF OPIOIDS AND BENZODIAZEPINES HANNON ACT COMMITTEE |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗